GL1X · GenesisL1 explorer

MolNFT v1 · #185998 · protein

Botulinum neurotoxin A5 cell binding domain in complex with GM1B oligosaccharide

7QPU · Botulinum neurotoxin sub-type A5: “Botulinum neurotoxin A5 cell binding domain in complex with GM1B oligosaccharide”. X-ray diffraction, 3 ligands (GAL, SIA, SO4), 7 pockets (best druggability 0.81). MolNFT v1 #185998 on GenesisL1…

PDB
7QPU
Type
protein
Length
738 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin sub-type A5
EC
3.4.24.69
UniProt
C1IPK2
Ligands
GAL, SIA, SO4
Pockets
7 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin sub-type A5 (EC 3.4.24.69)protein3875% helix, 45% strandC1IPK2
BBotulinum neurotoxin sub-type A5 (EC 3.4.24.69)protein3515% helix, 45% strandC1IPK2

Ligands and binding sites

  • GAL · beta-D-galactopyranose · sugar · chains A
  • SIA · N-acetyl-alpha-neuraminic acid · sugar · chains A
  • SO4 · Sulfate ion · ion · chains B
  • PEG · Di(hydroxyethyl)ether · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17960.810.8465empty
22690.550.7727empty
32830.540.7628empty
4760.520.8520empty
5730.450.8220empty

Interfaces

1 interface between chains.

  • A–B · 746 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (additive adduct).

Compared structures

  • 7QPU · Botulinum neurotoxin A5 cell binding domain in complex with GM1b oligosaccharide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.